While future studies should delineate the exact underlying mechanism, our finding that xCT positive cancer cells are simultaneously resistant to lipid peroxidation insult yet hypersensitive to xCT or GPX4 inhibitors raises important therapeutic implications. Here, GPX4 is linked to cancer.